Benitez D, Cumplido-Laso G, Olivera-Gomez M, Del Valle-Del Pino N, Diaz-Pizarro A, Mulero-Navarro S
Biomedicines. 2024; 12(7).
PMID: 39062026
PMC: 11274425.
DOI: 10.3390/biomedicines12071453.
Das A, Chaudhary N, Tyagi S, Agarwal S
Genes (Basel). 2023; 14(3).
PMID: 36981012
PMC: 10048726.
DOI: 10.3390/genes14030741.
Diez-Quijada L, Puerto M, Gutierrez-Praena D, Turkina M, Campos A, Vasconcelos V
Toxins (Basel). 2022; 14(7).
PMID: 35878167
PMC: 9316492.
DOI: 10.3390/toxins14070429.
Alali H, Bloch I, Rapaport I, Rodrigues L, Sher I, Ansbacher T
Pharmaceuticals (Basel). 2022; 15(6).
PMID: 35745671
PMC: 9230431.
DOI: 10.3390/ph15060752.
Ziranu P, Lai E, Schirripa M, Puzzoni M, Persano M, Pretta A
Target Oncol. 2021; 16(4):517-527.
PMID: 33970400
PMC: 8266772.
DOI: 10.1007/s11523-021-00816-3.
Tumor-Associated Antigen xCT and Mutant-p53 as Molecular Targets for New Combinatorial Antitumor Strategies.
Magri J, Gasparetto A, Conti L, Calautti E, Cossu C, Ruiu R
Cells. 2021; 10(1).
PMID: 33430127
PMC: 7827209.
DOI: 10.3390/cells10010108.
Effects of triclosan on antioxidant- and apoptosis-related genes expression in the gill and ovary of zebrafish.
Wang F, Zheng F, Liu F
Exp Anim. 2019; 69(2):199-206.
PMID: 31839624
PMC: 7220719.
DOI: 10.1538/expanim.19-0115.
Association between MDM2 SNP309 and endometrial cancer risk: A PRISMA-compliant meta-analysis.
Zou X, Zhang Y, Zhang L, Li J, Zhu C, Cheng Q
Medicine (Baltimore). 2018; 97(49):e13273.
PMID: 30544386
PMC: 6310604.
DOI: 10.1097/MD.0000000000013273.
Identification of new inhibitors of Mdm2-p53 interaction via pharmacophore and structure-based virtual screening.
Atatreh N, Ghattas M, Bardaweel S, Al Rawashdeh S, Al Sorkhy M
Drug Des Devel Ther. 2018; 12:3741-3752.
PMID: 30464405
PMC: 6223338.
DOI: 10.2147/DDDT.S182444.
Liver Cancer Initiation Requires p53 Inhibition by CD44-Enhanced Growth Factor Signaling.
Dhar D, Antonucci L, Nakagawa H, Kim J, Glitzner E, Caruso S
Cancer Cell. 2018; 33(6):1061-1077.e6.
PMID: 29894692
PMC: 6005359.
DOI: 10.1016/j.ccell.2018.05.003.
Tan IIA inhibits H1299 cell viability through the MDM4‑IAP3 signaling pathway.
Zu Y, Wang J, Ping W, Sun W
Mol Med Rep. 2017; 17(2):2384-2392.
PMID: 29207086
PMC: 5783490.
DOI: 10.3892/mmr.2017.8152.
How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression?.
Aubrey B, Kelly G, Janic A, Herold M, Strasser A
Cell Death Differ. 2017; 25(1):104-113.
PMID: 29149101
PMC: 5729529.
DOI: 10.1038/cdd.2017.169.
The Functional Roles of the MDM2 Splice Variants P2-MDM2-10 and MDM2-∆5 in Breast Cancer Cells.
Huun J, Gansmo L, Mannsaker B, Iversen G, Sommerfelt-Pettersen J, Ovrebo J
Transl Oncol. 2017; 10(5):806-817.
PMID: 28844019
PMC: 5576977.
DOI: 10.1016/j.tranon.2017.07.006.
promoter del1518 polymorphism and cancer risk: evidence from 22,931 subjects.
Hua W, Zhang A, Duan P, Zhu J, Zhao Y, He J
Onco Targets Ther. 2017; 10:3773-3780.
PMID: 28794641
PMC: 5538693.
DOI: 10.2147/OTT.S140424.
Isorhynchophylline, a Potent Plant Alkaloid, Induces Apoptotic and Anti-Metastatic Effects in Human Hepatocellular Carcinoma Cells through the Modulation of Diverse Cell Signaling Cascades.
Lee H, Baek S, Lee J, Kim C, Ko J, Lee S
Int J Mol Sci. 2017; 18(5).
PMID: 28534824
PMC: 5455004.
DOI: 10.3390/ijms18051095.
Nicotinamide nucleotide transhydrogenase (NNT) deficiency dysregulates mitochondrial retrograde signaling and impedes proliferation.
Ho H, Lin Y, Lin G, Wu P, Cheng M
Redox Biol. 2017; 12:916-928.
PMID: 28478381
PMC: 5426036.
DOI: 10.1016/j.redox.2017.04.035.
Impact of the MDM2 splice-variants MDM2-A, MDM2-B and MDM2-C on cytotoxic stress response in breast cancer cells.
Huun J, Gansmo L, Mannsaker B, Iversen G, Ovrebo J, Lonning P
BMC Cell Biol. 2017; 18(1):17.
PMID: 28415963
PMC: 5393014.
DOI: 10.1186/s12860-017-0134-z.
The role of p53 in cancer drug resistance and targeted chemotherapy.
Hientz K, Mohr A, Bhakta-Guha D, Efferth T
Oncotarget. 2016; 8(5):8921-8946.
PMID: 27888811
PMC: 5352454.
DOI: 10.18632/oncotarget.13475.
Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
Lu X, Yan C, Huang Y, Shi D, Fu Z, Qiu J
Oncotarget. 2016; 7(24):37177-37191.
PMID: 27184007
PMC: 5095067.
DOI: 10.18632/oncotarget.9287.
Bifurcation in Cell Cycle Dynamics Regulated by p53.
Alam M, Kumar S, Singh V, Brojen Singh R
PLoS One. 2015; 10(6):e0129620.
PMID: 26090895
PMC: 4474887.
DOI: 10.1371/journal.pone.0129620.